Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

Valganciclovir (VGC) is an oral prodrug of ganciclovir (GCV) recently introduced for prophylaxis and treatment of cytomegalovirus infection. Optimal concentration exposure for effective and safe VGC therapy would require either reproducible VGC absorption and GCV disposition or dosage adjustment bas...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Perrottet, N., Csajka, C., Pascual, M., Manuel, O., Lamoth, F., Meylan, P., Aubert, J. D., Venetz, J. P., Soccal, P., Decosterd, L. A., Biollaz, J., Buclin, T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology (ASM) 2009
Ämnen:
Antiviral Agents
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704634/
https://ncbi.nlm.nih.gov/pubmed/19307355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00836-08
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk